Iranian Researchers Produce Primary Ingredients of MS, Intestinal Inflammation Drugs
8:05 - January 15, 2023

Iranian Researchers Produce Primary Ingredients of MS, Intestinal Inflammation Drugs

TEHRAN (ANA)- Vice-President of Alborz University of Medical Sciences for Research and Technology announced production of raw materials for the treatment of MS disease and intestinal inflammation by the Iranian researchers.
News ID : 1323

Razieh Lotfi, the Vice President of Alborz University of Medical Sciences for Research and Technology, elaborated on the products presented by several knowledge-based companies in a recent provincial exhibition, and said, “Medical pillows with variable height, chemical pharmaceutical raw materials, vegetable and fruit disinfection tablets, absorbent pads for protein products, pyrolysis device (medical waste), new herbal medicines were among the important and technological products of the health sector presented in the exhibition by Alborz University of Medical Sciences.”

“Other products included a digital device for measuring the sensation of pain in humans, mouthwash solution, ginger suppositories, raw materials for the production of MS drugs, raw materials for the production of intestinal inflammation disease drugs, formulation for hydrocortisone mucus adhesive tablet, soybean extract mask formulation (anti-wrinkle ointment), formulation for Vitiligo (leprosy) disease and formulation of the scorpion oil for topical pain,” she added.

Multiple Sclerosis (MS) is a condition that can affect the brain and spinal cord, causing a wide range of potential symptoms, including problems with vision, arm or leg movement, sensation or balance.

It's a lifelong condition that can sometimes cause serious disability, although it can occasionally be mild.

4155/v

 

 

Send comment